Cheek Augmentation — structure, projection, definition.

Augmentation adds projection or volume. A lift repositions descended tissue. The examination determines whether the concern is deficiency, depletion, descent, or a combination.

They are designed as long-term implants but can be removed or revised. Position, tissue response, aging, infection, trauma, or changing preferences may lead to future surgery.

Fat retention varies. The surgeon can control placement, but not every transferred cell survives. Asymmetry, under-correction, over-correction, irregularity, and need for repeat treatment are possible.

Filler can demonstrate how added volume changes the face, but it does not exactly reproduce an implant’s shape, plane, or long-term behavior. It also changes the tissue being examined.

It may soften folds when midface support or volume contributes, but it does not erase every fold and should not be oversized for that purpose.

We assess skeletal projection, soft‑tissue volume, and skin quality. If the underlying zygoma is flat or the infraorbital rim lacks support, skeletal augmentation (implant or structural fat graft) is favored. If soft‑tissue volume loss predominates with good skin elasticity, fillers or fat grafting may suffice. Prior surgery, scar tissue, and facial animation are also reviewed before recommending a technique.

Increasing midface projection can lift the nasolabial fold and restore perceived jawline definition by changing the relationship between cheek and mandible. Proper vectoring avoids unwanted fullness in the buccal region and maintains natural transition zones. Overprojection can exaggerate lower‑face shadows; judgment about projection is essential. We evaluate chin position and often discuss concurrent lower‑face procedures for overall balance.

Implants are considered when skeletal support is the primary deficit or when predictable, long‑term projection is required. Fat grafting is preferred for patients desiring autologous tissue, simultaneous correction of adjacent hollows, or modest augmentation. Patients with prior extensive midface scarring or infection risk require individualized planning. Final candidacy is determined in clinic with physical exam and imaging.

After hyaluronic fillers, most swelling and ecchymosis resolve within 24–72 hours, though subtle fullness may last longer. Fat grafting typically produces 5–14 days of visible swelling with social downtime often under two weeks. Surgical implants usually cause most noticeable swelling for 10–14 days, with gradual improvement over several weeks. Individual healing varies with anesthesia type, operative extent, and patient factors.

Malar implants are most often placed through intraoral incisions inside the mouth beneath the upper lip, which leaves no external scar. Some approaches use a lower eyelid incision when concurrent eyelid surgery is planned; in that case, incisions are placed in natural creases. Implant position is secured to minimize migration and to respect the facial animation vectors. Scars are typically well‑concealed when standard approaches are used.

Yes — prior fillers can create palpable nodules or interfere with implant seating; knowledge of product type and timing is important. Recent injectable treatments may require delay before surgery to allow tissue settling. Fat grafting history informs expectations for additional retention and contour changes. We review prior treatment records and may obtain imaging to guide safe planning.